Particularly for solid oral dosage forms, both conventional and extended or modified release. The formulation development will include development on laboratory scale, pilot scale and manufacturing scale including packaging development.

The data shall be supported by the stability studies conducted based on ICH guidelines, analytical method development for the formulations, the dissolution profiles and complete documentation.